Best Buy Inc (BBY) Falls 4.52% for January 19

Equities Staff |

One of the S&P 500’s big losers for Tuesday January 19 was Best Buy Inc (BBY). The company’s stock fell 4.52% to $25.89 on volume of 7.42 million shares.

The stock opened the day at 27.05 and traded between a low of $25.40 and a high of $27.10. The stock finished the day down $1.225 per share. Best Buy Inc has an average daily volume of 5.15 million and a total float of 342.72 million shares. The 50-day SMA for Best Buy Inc is $30.89 and its 200-day SMA is $33.60. The high for the stock over the last 52 weeks is $42.00 and the low is $25.31.

Best Buy Co Inc is a retailer of technology products, including tablets and computers, televisions, mobile phones, large and small appliances, entertainment products, digital imaging and related accessories.

Best Buy Inc is centered in Richfield, MN, and has 125,000 employees. Today’s trading day leaves the company with a market cap of $8.87 billionwith a P/E Ratio of 10.2. The company has a P/S ratio of 0.24, P/B ratio of 1.91, and a 14.9.

For a complete fundamental analysis analysis of Best Buy Inc, check out Equities.com’s Stock Valuation Analysis report for BBY. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Spotify

Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…

Cloudera

Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…